Prof. Dr. Monika Kirsch
Professorin für Angewandte Gesundheits- und Pflegewissenschaften
Erzbergerstraße 121, Raum B570.3
- Telefon:
- +49.721.9735-857
- E-Mail:
- monika.kirsch@dhbw-karlsruhe.de
Wissenschaftliche Ausbildung
|
2010 ‑ 2014 |
Wissenschaftliche Mitarbeiterin und Promotion am Institut für Pflegewissenschaft, Universität Basel |
|
2006 ‑ 2009 |
Studium der Pflegewissenschaft am Institut für Pflegewissenschaft, Universität Basel |
Berufliche Tätigkeiten
|
seit Januar 2022 |
Professorin für Angewandte Gesundheits- und Pflegewissenschaften, DHBW Karlsruhe |
|
2021 |
Elternzeit |
|
2015 ‑ 2021 |
Pflegeexpertin, Advanced Practice Nurse (APN) Schmerztherapie Abteilung Schmerztherapie am Department für Anästhesiologie, Universitätsspital Basel |
|
2010 ‑ 2015 |
Pflegeexpertin (APN) Hämatologie Zellersatzambulatorium & Tagesklinik, Stammzelltransplantationszentrum, Universitätsspital Basel |
|
2005 ‑ 2010 |
Pflegefachfrau Innere Medizin/Onkologie und Isolierstation, Stammzelltransplantationszentrum, Universitätsspital Basel |
|
2003 ‑ 2004 |
Pflegefachfrau Chrischona Klinik, Bürgerspital Basel |
|
2000 ‑ 2003 |
Ausbildung zur examinierten Krankenschwester Krankenpflegeschule Kreiskrankenhaus Dormagen |
Lehrgebiete
- Pflegetheorie und Forschung
- Erweiterte Pflegepraxis
- Onkologische Pflege und Schmerztherapie
- Pflegeassessment und -diagnostik
Forschungsgebiete
- Patientenselbstmanagement
- Symptommanagement
- Praxisentwicklung in der Pflege
Veröffentlichungen
2021
-
(2021): Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient's perspective?. In: Support Care Cancer 6 (Jun;29(6)), S. 3129-3135. DOI: 10.1007/s00520-020-05816-z
2020
-
(2020): Zusammenfassung von zwei Studien zur Validierung des Critical Care Pain Observation Tool (CPOT) zur Beurteilung von Schmerzen bei nichtäußerungsfähigen Intensivpatienten. In: Anaesthesist 7 (69), S. 487-488. DOI: 10.1007/s00101-020-00799-2
2019
2018
-
(2018): Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study. In: Supportive Care in Cancer 3 (26), S. 833-841. DOI: 10.1007/s00520-017-3897-z
-
(2018): Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. In: European journal of cardiovascular nursing 17 (4), S. 356-367. DOI: 10.1177/1474515117747577
DOI: http://www.ncbi.nlm.nih.gov/pubmed/29231747 Abstract: BACKGROUND As medication non-adherence is a major risk factor for poor post-transplant outcomes, we explored how adherence is assessed, enhanced and integrated across the transplant continuum. AIM The aim of this study was to study practice patterns regarding pre- and post-transplant medication adherence assessment and interventions in international heart transplant centres. METHODS We used data from the Building Research Initiative Group: chronic illness management and adherence in heart transplantation (BRIGHT) study, a cross-sectional study conducted in 36 heart transplant centres in 11 countries. On a 27-item questionnaire, 100 clinicians (range one to five per centre) reported their practice patterns regarding adherence assessment and intervention strategies pre-transplant, immediately post-transplant, less than one year, and one or more year post-transplant. Educational/cognitive, counselling/behavioural and psychosocial/affective strategies were assessed. Clinicians' responses (intervention present vs. absent; or incongruence in reporting intervention) were aggregated at the centre level. RESULTS The adherence assessment method most commonly used along the transplant continuum was questioning patients (range 75-88.9%). Pre-transplant, all three categories of intervention strategy were applied. Providing reading materials (82.9%) or instructions (68.6%), involving family or support persons in education (91.4%), and establishing partnership (91.4%) were used most frequently. Post-transplant, strategies closely resembled those employed pre-transplant. Training patients (during recovery) and cueing were more often applied during hospitalisation (74.3%). After the first year post-transplant, except for motivational interviewing (25.7-28.6%), the number of strategies decreased. CONCLUSIONS Across the transplant continuum, diverse adherence interventions are implemented; however, post-transplant, the frequency of adherence interventions decreases. Therefore, increased investment is necessary in long-term adherence interventions.
2017
-
(2017): Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study. In: Bone marrow transplantation 52 (12), S. 1686-1688. DOI: 10.1038/bmt.2017.204
-
(2017): Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study. In: Bone marrow transplantation 52 (2), S. 304-306. DOI: 10.1038/bmt.2016.262
-
(2017): Perception of late effects among long-term survivors after haematopoietic stem cell transplantation. Descriptive analysis and validation of the Brief Illness Perception Questionnaire. A sub-study of the PROVIVO study. In: Eur J Oncol Nurs, S. 17-27. DOI: 10.1016/j.ejon.2017.01.003